A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
Observational
Observational Model: Cohort, Time Perspective: Prospective
Assess the ability of a mononuclear-cell gene signature to predict the presence of metastatic cancer in the regional L.N. of patients with muscle-invasive bladder cancer at the time of cystectomy with PLND for presumed localized muscle-invasive disease.
2 years
No
Guido Dalbagni, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
09-054
NCT00918008
June 2009
June 2014
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
New York Presbyterian Hospital-Weill Medical College of Cornell University | New York, New York 10065 |